Page 14 - Crispr News Today

The first treatment that relies on CRISPR is expected to receive U.S. approval next month. But it may cost millions of dollars per patient.

Initial data from a human clinical trial suggests an experimental drug from Verve Therapeutics that uses gene editing to permanently lower cholesterol raises hopes that people can one day trade daily lipid-lowering pills for a one-time treatment

It’s still early days for a novel form of gene therapy called base editing, but this small study in people with extremely high cholesterol shows striking results.

A small trial of a cholesterol-lowering treatment based on CRISPR gene editing has produced promising results, but there are questions over safety

New therapies are on the horizon for genetic neuromuscular diseases, and this will raise both hopes for patients and challenges for neurologists.

The gene-editing technology known as CRISPR has led to revolutionary changes in agriculture, health research and more.

Stopping metformin was linked to an increased risk for dementia diagnosis in a large cohort of adults with T2D, providing more evidence of the drug’s potential neuroprotective effects.

Sickle cell disease is a painful, debilitating, and possibly deadly inherited disorder that currently can only be remedied with a bone marrow transplant. Now, Boston's Vertex...

A panel of advisers to the regulator said on Tuesday Vertex Pharmaceuticals and CRISPR Therapeutics could assess potential safety risks of their sickle cell disease gene therapy after approval.

The decision by an advisory committee may lead to Food and Drug Administration approval of the first treatment for humans that uses the CRISPR gene-editing system.